Pioneering Technology, Shaping Tomorrow| Genedart Shines at the 28th Beijing International High-Tech Expo
180
2026-05-11
From May 8 to 10, 2025, Genedart made a significant appearance at the 28th China Beijing International High-Tech Expo (CHITEC). During the exhibition, Genedart showcased its cutting-edge technology and green manufacturing philosophy, clearly demonstrating the revolutionary potential of synthetic biology industrialization. The company attracted numerous industry experts, government representatives, and partners for in-depth discussions.
This platform significantly compresses the cycle from project initiation to commercialization. By adhering to the underlying philosophy of green, natural, and sustainable production, and by building technological barriers through continuous strain optimization, Genedart provides solid support for the ongoing expansion of its product pipeline.
Market-oriented, data-driven, and AI-powered—every metabolic pathway at Genedart serves real industrial needs.
In future, Genedart will continue to focus on green natural products, accelerate the commercialization of products under development, and work with global partners to promote the high-quality development of the synthetic biology industry.
Full-Chain R&D Platform: A Complete Closed Loop from Data to Product
Genedart's self-developed "3x3x3" R&D platform—comprising Three Open-Source Database Mining Technologies, Three Development and Expansion Platforms, and Three Metabolic Derivative Platforms—operates in synergy to cover the entire R&D chain from data discovery and pathway design to strain engineering and large-scale production. Powered by the GeneDart Intelligent R&D System, the platform utilizes the DBTL cycle to drive digital collaboration between dry and wet labs. By deeply integrating AI models with experimental data, it continuously iterates and optimizes microbial cell factories, achieving a leap in both R&D efficiency and industrial scalability.This platform significantly compresses the cycle from project initiation to commercialization. By adhering to the underlying philosophy of green, natural, and sustainable production, and by building technological barriers through continuous strain optimization, Genedart provides solid support for the ongoing expansion of its product pipeline.
From Lab to Expo: The Convergence of Technology and Market
As one of the first synthetic biology companies in China to achieve a closed loop of "Independent R&D – Large-scale Production – Commercial Sales," Genedart has achieved stable supply of multiple products at a scale exceeding 100 tons. At this year's expo, key ingredients such as GreenVanil® Natural Vanillin and Kineflex™ Salidroside garnered widespread attention for their natural, safe, and multi-scenario application advantages, fully validating the market transformation capabilities of the technology platform.Market-oriented, data-driven, and AI-powered—every metabolic pathway at Genedart serves real industrial needs.
Looking to a Green Future: Embracing the New Era of Bio-manufacturing
Synthetic biology is at a critical juncture, transitioning from laboratory technology to a core industrial driver. As the deep integration of AI and life sciences accelerates, bio-manufacturing will reshape competitive landscapes across multiple trillion-dollar sectors, including new materials, healthcare, and the food industry.In future, Genedart will continue to focus on green natural products, accelerate the commercialization of products under development, and work with global partners to promote the high-quality development of the synthetic biology industry.
Share
